APW
MDGL icon

Aventura Private Wealth’s Madrigal Pharmaceuticals MDGL Stock Holding History

Aventura Private Wealth’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3K Hold
62
– – 0.01% 398
2026
Q1 		$32.5K Hold
62
– – 0.01% 380
2025
Q4 		$36.1K Hold
62
– – 0.01% 340
2025
Q3 		$28.4K Hold
62
– – 0.01% 358
2025
Q2 		$18.8K Hold
62
– – 0.01% 384
2025
Q1 		$20.5K Hold
62
– – 0.01% 353
2024
Q4 		$19.1K Buy
+62
New +$17.4K 0.01% 355

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aventura Private Wealth's MDGL Position: Q2 2026 in Review

Aventura Private Wealth held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 62 shares worth $33.3K. The position accounts for 0.01% of the portfolio, ranked #398.

Aventura Private Wealth first reported a position in MDGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $36.1K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Aventura Private Wealth held 62 shares of Madrigal Pharmaceuticals worth $33.3K as of Q2 2026.
  • Aventura Private Wealth left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #398 holding.
  • Aventura Private Wealth first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's Madrigal Pharmaceuticals position peaked at $36.1K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.